TScan Therapeutics Company
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Connections from
Founded Date:
2018-01-01
Total Funding:
137500000
Employee Number:
51-100
Last Funding Type:
Series C
Industry:
PharmTech
Headquarters:
Waltham, Massachusetts, United States
Funding Status:
IPO